Matches in Wikidata for { <http://www.wikidata.org/entity/Q63805114> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- Q63805114 description "artículu científicu espublizáu n'abril de 2015" @default.
- Q63805114 description "im April 2015 veröffentlichter wissenschaftlicher Artikel" @default.
- Q63805114 description "scientific article published on 13 April 2015" @default.
- Q63805114 description "wetenschappelijk artikel" @default.
- Q63805114 description "наукова стаття, опублікована у квітні 2015" @default.
- Q63805114 name "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 name "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 type Item @default.
- Q63805114 label "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 label "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 prefLabel "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 prefLabel "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 P1433 Q63805114-D03BFB4B-C492-4F00-B8B2-830092C3A085 @default.
- Q63805114 P1476 Q63805114-BD2E17C3-7A9E-422C-B4B7-5193742B3622 @default.
- Q63805114 P2093 Q63805114-17F45880-D589-4751-A0DC-BEB6C24FB457 @default.
- Q63805114 P2093 Q63805114-198BB559-8446-44CF-83B5-CEC2B43A7D4A @default.
- Q63805114 P2093 Q63805114-2B32033A-4E3A-424F-A31C-399343C9A808 @default.
- Q63805114 P2093 Q63805114-4C2A5FFB-448B-4053-8BBE-D3BD8BE9E6B5 @default.
- Q63805114 P2093 Q63805114-4F378BC7-FF4B-4787-99A9-4A5972E0094B @default.
- Q63805114 P2093 Q63805114-68E27056-6A46-46A7-BCB0-8DF3466A4FC1 @default.
- Q63805114 P2093 Q63805114-8181E4AC-B3EC-448C-9721-B429480BAEF0 @default.
- Q63805114 P2093 Q63805114-B63C5343-7490-4621-B929-1D904D9C4B28 @default.
- Q63805114 P2093 Q63805114-EA0A148C-2DC2-4A58-A470-8D79BB472270 @default.
- Q63805114 P304 Q63805114-BD217BC5-46A0-454F-B409-27C968F6BD34 @default.
- Q63805114 P31 Q63805114-9B564F22-09C5-44F0-8EE4-E01ADDD882A4 @default.
- Q63805114 P356 Q63805114-B0A6F328-78F8-4B92-96BA-C891F5D3DB24 @default.
- Q63805114 P433 Q63805114-25C415C8-0909-4B94-AA39-CE504F6A856E @default.
- Q63805114 P478 Q63805114-EA282B2C-3261-4760-8E9A-1C4DF6B4EAC0 @default.
- Q63805114 P50 Q63805114-0233B3C7-FB16-4AAE-9754-3A4D4FBEB550 @default.
- Q63805114 P50 Q63805114-83ED3B9E-8C10-4145-A243-C7EF5193FEC8 @default.
- Q63805114 P50 Q63805114-B8FDD17C-AABF-4191-A307-F6788BE61C96 @default.
- Q63805114 P50 Q63805114-BF48EC6D-CDE1-4766-BF9A-D66707E0F889 @default.
- Q63805114 P50 Q63805114-D059A670-B1CB-426A-9041-BAE2BD2968FD @default.
- Q63805114 P577 Q63805114-768313B8-FD35-43EC-BB4E-425F82341C03 @default.
- Q63805114 P698 Q63805114-78345CD9-C5DC-4D28-95BB-4FB61B17BFC9 @default.
- Q63805114 P921 Q63805114-755CEC9B-72A6-493E-B1A7-979E155695F5 @default.
- Q63805114 P921 Q63805114-9E3B6F1A-F550-4784-AD18-6A39CC84F937 @default.
- Q63805114 P921 Q63805114-A3DED633-DE4E-4AB7-B525-2CAF0B5CC8E5 @default.
- Q63805114 P356 DMD.115.063388 @default.
- Q63805114 P698 25870102 @default.
- Q63805114 P1433 Q1261140 @default.
- Q63805114 P1476 "Hepatoselective Nitric Oxide (NO) Donors, V-PYRRO/NO and V-PROLI/NO, in Nonalcoholic Fatty Liver Disease: A Comparison of Antisteatotic Effects with the Biotransformation and Pharmacokinetics" @default.
- Q63805114 P2093 "Agnieszka Kij" @default.
- Q63805114 P2093 "Agnieszka Zakrzewska" @default.
- Q63805114 P2093 "Anna Gonciarz-Dytman" @default.
- Q63805114 P2093 "Barbara Sitek" @default.
- Q63805114 P2093 "Edyta Maslak" @default.
- Q63805114 P2093 "Joseph E Saavedra" @default.
- Q63805114 P2093 "Krystyna Wandzel" @default.
- Q63805114 P2093 "Larry K Keefer" @default.
- Q63805114 P2093 "Ryan J Holland" @default.
- Q63805114 P304 "1028-1036" @default.
- Q63805114 P31 Q13442814 @default.
- Q63805114 P356 "10.1124/DMD.115.063388" @default.
- Q63805114 P433 "7" @default.
- Q63805114 P478 "43" @default.
- Q63805114 P50 Q19269781 @default.
- Q63805114 P50 Q30902432 @default.
- Q63805114 P50 Q60061972 @default.
- Q63805114 P50 Q63806210 @default.
- Q63805114 P50 Q96102496 @default.
- Q63805114 P577 "2015-04-13T00:00:00Z" @default.
- Q63805114 P698 "25870102" @default.
- Q63805114 P921 Q1546498 @default.
- Q63805114 P921 Q323936 @default.
- Q63805114 P921 Q6058862 @default.